Global Behcets Disease Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Behcets Disease or Behcet’s syndrome, is a rare disorder that causes blood vessel inflammation throughout the body. This is an autoinflammatory condition is where body’s natural defence against infection and illness – mistakenly attacks healthy tissue. The major symptoms of Behcets disease are genital and mouth ulcers, red, painful eyes and blurred vision, acne-like spots, headaches, painful, stiff, and swollen joints among others. The rise in incidences of Behcets disease worldwide and growing technological advancements in healthcare industry are key factor driving the market growth.

The increasing prevalence of Behcets disease is driving the global market growth. For instance – as per National Center for Biotechnology Information (NCBI) – as of December 2022, Turkey has the highest prevalence of Behcets disease affecting 420 people per 100,000 population. Additionally, In the United States, the prevalence is estimated at 5.2 people per 100,000 population. Moreover, Behcets UK’s estimates – in the United Kingdom the prevalence of Behcets disease is estimated at 0.64 people per 100,000 population. Also, increasing R&D expenditure in healthcare sector and growing prevalence of autoinflammatory conditions would create lucrative growth prospectus for the market over the forecast period. However, the lack of awareness towards Behcets Disease stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Behcets Disease Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the high prevalence of Behcets disease and growing healthcare sector in the region. Whereas North America is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising incidents of Behcets diseases and presence of leading market players in the North American region.

Major market player included in this report are:
Creabilis Limited
Cell Medica Limited
Actelion Ltd
Abbott Laboratories
Novartis AG
Les Laboratoires
Servier SAS
AbbVie Inc.
Celgene Corporation
F. Hoffmann La Roche Ltd.

Recent Developments in the Market:
? In July 2019, the U.S. Food and Drug Administration approved apremilast from Celgene Corporation for the treatment of oral ulcers associated with Behcet’s disease.


Global Behcets Disease Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Treatment Type, Symptoms, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type
Corticosteroids
Immunosuppressive Agents
Immunomodulators
By Symptoms
Eyes
Bowels
Skin and Mucosa
Lungs
Brain
Bones
Blood Vessels and Heart


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World